A detailed history of Roble, Belko & Company, Inc transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Roble, Belko & Company, Inc holds 71 shares of TMO stock, worth $36,428. This represents 0.01% of its overall portfolio holdings.

Number of Shares
71
Previous 71 -0.0%
Holding current value
$36,428
Previous $39,000 12.82%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

SELL
$528.82 - $599.43 $26,441 - $29,971
-50 Reduced 41.32%
71 $41,000
Q2 2022

Aug 10, 2022

SELL
$500.9 - $612.21 $11,019 - $13,468
-22 Reduced 15.38%
121 $66,000
Q1 2022

May 06, 2022

BUY
$524.0 - $644.92 $37,728 - $46,434
72 Added 101.41%
143 $84,000
Q1 2021

May 12, 2021

BUY
$439.85 - $518.83 $28,150 - $33,205
64 Added 914.29%
71 $32,000
Q3 2020

Nov 10, 2020

BUY
$359.77 - $441.52 $2,518 - $3,090
7 New
7 $3,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Roble, Belko & Company, Inc Portfolio

Follow Roble, Belko & Company, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roble, Belko & Company, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Roble, Belko & Company, Inc with notifications on news.